Metabolic Phases of Surgical Patients and Nutritional Implications

Ebb Phase (Early Shock)

• The ebb phase begins within minutes‑to‑hours after surgery and is characterized by hemodynamic instability with a reduced metabolic rate compared with the pre‑injury state. 1, 2
• Oxygen consumption and core body temperature fall as a survival mechanism. 3
• Marked hormonal shifts, including insulin resistance, redirect energy substrates to vital organs. 1, 2
• Endogenous glucose production rises via hepatic glycogenolysis. 1, 2
• Resting energy expenditure (REE) is lower than the pre‑operative baseline. 1, 3

Flow Phase (Catabolic)

• The flow (catabolic) phase follows the ebb phase and typically spans ICU days 1‑7. 1, 2, 3
• Intense tissue catabolism—especially skeletal muscle—provides amino acids (e.g., alanine, glutamine) for the “fight‑or‑flight” response. 1, 2, 4
• Hypermetabolism raises REE; the magnitude correlates with trauma severity. 5
• Muscle protein loss supplies substrates for wound healing, acute‑phase protein synthesis, and immune function. 6, 4
• Lipolysis and lipid oxidation increase while glucose oxidation declines, preserving protein stores. 6, 4
• Inflammatory mediators (TNF‑α, IL‑1, IL‑6, IL‑8) and stress hormones (catecholamines, cortisol, glucagon) are released. 6, 4
• A tendency toward water and sodium retention is mediated by catabolic hormones. 3
• Nutritional therapy can meet energy needs for wound repair but only minimally attenuates or fails to reverse muscle catabolism. 6, 4

Anabolic Recovery Phase (Convalescence)

• The recovery phase usually starts after ICU day 7 and may continue for several weeks. 1, 2, 3
• Lost tissue, particularly muscle mass, is resynthesized once the patient’s metabolism can adequately process nutrients. 1, 2
• Excess water and sodium accumulated in earlier phases are excreted. 3
• Weight gain during recovery reflects an increase in fat‑free (lean) mass rather than fluid overload. 3
• Nutrient utilization improves, supporting cellular rebuilding and peripheral protein synthesis. 1, 2, 6
• Successful restoration of peripheral protein mass requires proper management of surgical trauma/infection together with targeted nutrition and physical activity. 6, 4

Clinical Guidelines & Timing (ESPEN)

• No validated clinical marker reliably signals the transition between metabolic phases. 1, 2
• The ESPEN (European Society for Clinical Nutrition and Metabolism) guidelines adopt a pragmatic time‑based terminology:
  
  • Early acute phase – ICU days 1‑2
  • Late acute phase – ICU days 3‑7
  • Recovery phase – after ICU day 7
• A “one‑size‑fits‑all” or “set‑and‑forget” nutrition strategy is discouraged; individualized nutrition that adapts to evolving metabolic, hormonal, and immune changes is essential, especially in later stages of critical illness. 1, 2

Metabolic Phases of Trauma and Evidence‑Based Nutritional Management

1. Immediate (Ebb/Shock) Phase – Minutes to Hours After Injury

• Marked hormonal changes, including insulin resistance, redirect energy substrates toward vital organs – the body prioritizes glucose delivery to the brain, heart and lungs while peripheral tissues become hypometabolic. Critical Care (2020) 7 – observational data.
• Hemodynamic stabilization should be prioritized over aggressive nutrition because endogenous glucose production is already elevated and resting energy expenditure (REE) is reduced. Critical Care (2020) 7 – expert recommendation based on physiological studies.
• Early aggressive caloric feeding is not beneficial and may be harmful; recent randomized controlled trials showed no improvement in outcomes and a trend toward increased complications when substantial energy is delivered during the low‑metabolism period. Critical Care (2020) 7 – Level 1 evidence (RCT).

2. Immune (Catabolic/Flow) Phase – Days 1‑7 in the ICU

• Temporal sub‑division endorsed by ESPEN:
  
  • Early acute phase = ICU days 1‑2.
  • Late acute phase = ICU days 3‑7.
    These intervals are based on expert consensus rather than validated biomarkers. Clinical Nutrition* (2019) 8 – expert opinion.
• No validated clinical marker reliably indicates the transition between metabolic phases; clinicians must rely on time‑based definitions and clinical judgment. Clinical Nutrition (2019) 8 – expert opinion.

3. Late (Anabolic/Recovery) Phase – After ICU Day 7

• Nutritional support becomes physiologically more effective; provision of adequate calories and protein supports muscle protein synthesis and tissue repair once oxidative metabolism is restored. Critical Care (2020) 7 – observational data.

4. Clinical Evidence and Guideline Implications

• Most nutrition trials have intervened during the acute catabolic period, despite the recognition that nutrients are better utilized in the later anabolic phase. This mismatch may explain the lack of benefit seen in early feeding studies. Critical Care (2020) 7 – systematic review of trial designs.
• Recent high‑quality RCTs do not support early aggressive nutrition; they found no mortality or morbidity advantage and suggested possible harm when large energy loads are given before the patient’s metabolic capacity recovers. Critical Care (2020) 7 – Level 1 evidence (RCT).
• ESPEN adopts a pragmatic, time‑based terminology for metabolic phases because of the absence of validated biomarkers; the classification reflects consensus among experts and aligns with typical ICU length of stay. Clinical Nutrition (2019) 8 – expert consensus.
• The time‑based classification also guides study design, acknowledging that average ICU stay influences when interventions can be meaningfully applied. Critical Care (2020) 7 and Clinical Nutrition (2019) 8 – expert consensus.

Protein and Amino‑Acid Management in Severe Trauma

Inevitable Muscle Loss

• In patients with severe trauma or sepsis, loss of lean tissue occurs despite aggressive nutritional support, indicating that muscle catabolism cannot be fully prevented. 9

Amino‑Acid Dosage for Protein Preservation

• Administration of amino acids at 1.3–1.5 g /kg / day provides the most effective preservation of body protein in traumatized patients; higher doses do not confer additional benefit. 9

Glutamine Supplementation

• When parenteral nutrition is indicated, supplementation with 0.2–0.4 g /kg / day of L‑glutamine (equivalent to 0.3–0.6 g /kg / day of the alanine‑glutamine dipeptide) is recommended to support protein metabolism. 9

Early Enteral Nutrition and Amino‑Acid Provision

• Initiating enteral feeding within 24–48 hours after injury, starting at a trophic rate and advancing to target calories once hemodynamic stability is achieved, should include amino‑acid provision of 1.3–1.5 g /kg / day when parenteral nutrition is used. 9

• Despite optimal amino‑acid dosing, the catabolic response remains inevitable; nutrition can only mitigate but not eliminate loss of lean mass in the acute phase. 9

Nitrogen Management in Acute Renal Replacement Therapy

• In patients with acute kidney injury receiving continuous renal replacement therapy, a high nitrogen intake of 0.4 g N /kg / day can achieve a positive nitrogen balance. 9

Increased Nitrogen Needs with Hypocaloric Feeding

• When hypocaloric nutrition is employed, nitrogen requirements rise by approximately 25–30 % compared with standard caloric regimens. 9